Trademark Search in Canada

QUICKMELTS

View On IC.GC.CA

REGISTERED

on 28 Sept 2022

Last Applicant/ Owned by

VESPYR BRANDS LLC

c/o Aurobindo Pharma USA, Inc.279 Princeton Highstown RoadEast Windsor, NJ 08520

Serial Number

2029839 filed on 21^st May 2020

Registration Number

TMA1143621 registered on 28^th Sept 2022

Registration expiry Date

28^th Sept 2032

Correspondent Address

BENNETT JONES LLP

SUITE 3400, ONE FIRST CANADIAN PLACEP.O. BOX 130TORONTO

ONTARIO

M5X1A4

QUICKMELTS

Trademark usage description

orally disintegrating tablets, orally disintegrating medicaments, and medicaments all for reducing the duration and severity of the common cold and sy Read More

Classification Information

Class [005]
Orally disintegrating tablets, orally disintegrating medicaments, and medicaments all for reducing the duration and severity of the common cold and symptoms thereof.

Classification kind code

Mark Details

Serial Number

2029839

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 3^rd May 2022	Approved
Submitted for opposition 135 on 15^th Mar 2022	Amendment to Application
Submitted for opposition 135 on 31^st Jan 2022	Amendment to Application
Submitted for opposition 22 on 16^th Sept 2021	Search Recorded
Submitted for opposition 20 on 16^th Sept 2021	Examiner's First Report
Submitted for opposition 80 on 1^st Sept 2021	Change of Title Registered
Submitted for opposition 48 on 1^st Sept 2021	Agent Changed
Submitted for opposition 30 on 21^st May 2020	Filed
Submitted for opposition 1 on 21^st May 2020	Created
Submitted for opposition 31 on 21^st May 2020	Formalized

QUICKMELTS

Classification Information

Class [005]Orally disintegrating tablets, orally disintegrating medicaments, and medicaments all for reducing the duration and severity of the common cold and symptoms thereof.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Orally disintegrating tablets, orally disintegrating medicaments, and medicaments all for reducing the duration and severity of the common cold and symptoms thereof.